CD8+ T cell differentiation limits the response of CD8+ T cells to immune checkpoint blockade, thereby contributing to immune checkpoint blockade failure in a subset T cell-infiltrated lung cancer [22]. This evidence concerns the gene CD8A and lung carcinoma.